Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Oaknin%2C+Ana%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Oaknin%2C+Ana%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation : Final overall survival results from the OPINION trial
Poveda, Andrés ; Lheureux, Stéphanie ; Colombo, Nicoletta ; Cibula, David ; Elstrand, Mari ; Weberpals, Johanne ; Bjurberg, Maria ^LU ; Oaknin, Ana ; Sikorska, Magdalena and González-Martín, Antonio , et al. (2025) In Gynecologic Oncology 197. p.74-82
- Contribution to journal › Article
2024
Mark Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Vergote, Ignace ; Gonzalez-Martin, Antonio ; Fujiwara, Keiichi ; Kalbacher, Elsa ; Bagameri, Andrea ; Ghamande, Sharad ; Lee, Jung Yun ; Banerjee, Susana ; Maluf, Fernando Cotait and Lorusso, Domenica , et al. (2024) In New England Journal of Medicine 391(1). p.44-55
- Contribution to journal › Article
2010
Mark Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
Audeh, M. William ; Carmichael, James ; Penson, Richard T. ; Friedlander, Michael ; Powell, Bethan ; Bell-McGuinn, Katherine M. ; Scott, Clare ; Weitzel, Jeffrey N. ; Oaknin, Ana and Loman, Niklas ^LU , et al. (2010) In The Lancet 376(9737). p.245-251
- Contribution to journal › Article